These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 2501384)

  • 21. cDNA cloning and partial characterization of amastigote specific surface protein from Trypanosoma cruzi.
    Olivas-Rubio M; Hernández-Martínez S; Talamás-Rohana P; Tsutsumi V; Reyes-López PA; Rosales-Encina JL
    Infect Genet Evol; 2009 Dec; 9(6):1083-91. PubMed ID: 19481174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and partial characterization of a 28 kDa antigenic protein of Trypanosoma cruzi.
    Abate T; Rosenberg M; Aldao RR; Slezynger TC
    Biol Res; 1993; 26(1-2):121-30. PubMed ID: 7670524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania amazonensis: cultivation and characterization of axenic amastigote-like organisms.
    Hodgkinson VH; Soong L; Duboise SM; McMahon-Pratt D
    Exp Parasitol; 1996 Jun; 83(1):94-105. PubMed ID: 8654556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.
    Matsumoto TK; Hoshino-Shimizu S; Nakamura PM; Andrade HF; Umezawa ES
    J Clin Microbiol; 1993 Jun; 31(6):1486-92. PubMed ID: 8314991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of a 92-KD surface molecule of Trypanosoma cruzi amastigotes recognized by a monoclonal antibody that induces complement-mediated killing.
    Iida K; Ley V
    Am J Trop Med Hyg; 1991 Nov; 45(5):619-28. PubMed ID: 1951873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a competitive antibody enzyme immunoassay for specific diagnosis of Chagas' disease.
    Cuna WR; Rodriguez C; Torrico F; Afchain D; Loyens M; Desjeux P
    J Parasitol; 1989 Jun; 75(3):357-9. PubMed ID: 2498492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An iron-binding Trypanosoma cruzi urinary antigen.
    Corral RS; Bertot GM; Petray PB; Altcheh JM; Singh M; Orn A; Rapoport MF; Grinstein S
    Parasite; 1995 Dec; 2(4):339-44. PubMed ID: 8745735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of Trypanosoma cruzi, T. cruzi marinkellei, T. dionisii and T. vespertilionis by monoclonal antibodies.
    Petry K; Baltz T; Schottelius J
    Acta Trop; 1986 Mar; 43(1):5-13. PubMed ID: 2424290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parasite specific antibodies in three strains of mice after infection with Trypanosoma cruzi.
    Zweerink HJ; Anderson OF; Greenblatt HC; Murray PK
    J Parasitol; 1985 Feb; 71(1):43-9. PubMed ID: 3920376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells.
    Turner CW; Lima MF; Villalta F
    Biochem Biophys Res Commun; 2002 Jan; 290(1):29-34. PubMed ID: 11779128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family.
    Santos MA; Garg N; Tarleton RL
    Mol Biochem Parasitol; 1997 May; 86(1):1-11. PubMed ID: 9178263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A; Plumas-Marty B; Guevara-Espinoza A; Schöneck R; Pessoa H; Loyens M; Piras R; Aguirre T; Gras-Masse H; Bossus M
    J Immunol; 1993 Sep; 151(5):2676-89. PubMed ID: 7689612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface antigens of Trypanosoma cruzi: use of monoclonal antibodies to identify and isolate an epimastigote specific glycoprotein.
    Snary D; Ferguson MA; Scott MT; Allen AK
    Mol Biochem Parasitol; 1981 Oct; 3(6):343-56. PubMed ID: 6795502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular approaches to diagnosis of Chagas' disease: use of defined antigens and a target ribosomal RNA sequence.
    Zingales B; Golgher DB; Marmorato PG; Souto RP; Gruber A
    Biol Res; 1993; 26(1-2):89-100. PubMed ID: 7670551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of antigen preparations of the amastigote stage of Trypanosoma cruzi in the serology of Chagas' disease.
    Araujo FG; Guptill D
    Am J Trop Med Hyg; 1984 May; 33(3):362-71. PubMed ID: 6428245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi: amastigote polymorphism defined by monoclonal antibodies.
    Verbisck NV; Da-Silva S; Mortara RA
    Braz J Med Biol Res; 1998 Dec; 31(12):1583-91. PubMed ID: 9951555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies to stages of Trypanosoma cruzi: characterization and use for antigen detection.
    Araujo FG; Sharma SD; Tsai V; Cox P; Remington JS
    Infect Immun; 1982 Jul; 37(1):344-9. PubMed ID: 6809632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface antigens of stocks and clones of Trypanosoma cruzi isolated from humans.
    Zingales B; Abuin G; Romanha AJ; Chiari E; Colli W
    Acta Trop; 1984 Mar; 41(1):5-16. PubMed ID: 6201059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.
    Norris KA; Harth G; So M
    Infect Immun; 1989 Aug; 57(8):2372-7. PubMed ID: 2663722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.